Please assess the completion status of the following clinical trial:

Trial Title: Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria Part A:~* Male gender~* Age between 18 to 50 years included,~* 18 ≤ Body Mass Index (BMI) \< 30 kg/m²,~* Who had given their written consent for their participation in the study,~* Who, in the judgement of the Investigator, are likely to be compliant during the study,~* Registered with a social security insurance system.~Inclusion Criteria Part B:~* Aged 40 to 65 years-old,~* 18 ≤ BMI \< 35 kg/m2,~* Smokers ≥ 10 packs / year,~* Moderate to severe COPD~* Registered with a social security insurance system.~Exclusion Criteria Part A:~* History of asthma or significant respiratory disorder,~* History of allergic rhinitis,~* Upper respiratory tract infection in the last month,~* Blood eosinophil count ≥ 600/μL,~* Epilepsy, narrow angle glaucoma, prostatic hypertrophy or bladder neck obstruction,~* Abnormal spirography,~Exclusion Criteria Part B:~* Respiratory tract infection in the last 6 weeks,~* Asthma or significant respiratory disorder other than COPD,~* Allergic rhinitis,~* Blood eosinophil count ≥ 600/μL,~* Epilepsy, narrow angle glaucoma, moderate to severe prostatic hypertrophy or bladder neckobstruction,~* Myocardial infarction within the previous 6 months, heart failure or serious cardiac arrhythmia,~* Moderate to severe renal impairment,~* Moderate to severe hepatic impairment~* Use of short-acting b-agonist,~* Use of anticholinergics

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- V0162 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).